It is possible that SNG001 could be given as a treatment to patients with confirmed SARS-CoV-2 infection in order to prevent/limit the worsening of lower respiratory tract illness. We first need to test the study medication to see if it can ‘switch on’ the antiviral defences in the lungs in a way which would help them to fight viruses. The study medication will be given in addition to the normal medical care that patients should receive.
The trial has been adopted by the NIHR Respiratory Translational Research Collaboration, which is comprised of leading centres in respiratory medicine in the UK whose internationally recognised experts are working together to accelerate development and discovery for COVID-19. This is from today’s RNS and is very positive.
RE: Urgent public health study...meaning14 Apr 2020 15:03
To ensure that this kind of research can start as soon as possible, in some cases the HRA and devolved administrations are able to fast-track the review of a study. This means that researchers receive approval to begin much more quickly than the usual timelines, sometimes in a matter of hours. https://www.hra.nhs.uk/about-us/news-updates/research-public-health-emergency/
RE: AZN Trial halted Due to Overwhelming benefit..13 Apr 2020 23:11
Manifesto - ADAURA is a randomised, double-blinded, global, placebo-controlled Phase III trial in the adjuvant treatment of lung cancer. So, it has nothing to do with SNG.
RE: interferon used in tonji hosptial shanghai and other medical institutions13 Apr 2020 14:42
Justdeezerts good find. This study is about interferon alpha 2b. There are many different types of interferon. Most importantly interferon beta 1a, used by SNG, is more potent inhibitor of Coronavirus.
Woodsotck1970, just like you I got in NCYT at£.60 and got out at £1.25. Although made a good amount considering the carnage in all other share gutted looking at the current NCYT price. I also thought that testing can not go on for ever. How wrong. Anyway SNG is here to stay. Even before the results are out, in 8 weeks, we will be way beyond the FINCAPP guide price £1.20 just on the fact that the trial is simultaneously going on in multiple countries.